Pessary Market
Surge in expenditure on incontinence to boost pessary demand: Opportunities ahead
Pessary Market by Type, End-Use, & Region | Forecast 2023 to 2033
Pessary Market Outlook (2022 to 2032)
A newly released Pessary Market analysis report by Future Market Insights shows that global sales of the Pessary Market in 2021 were held at US$ 289.8 Million. With a CAGR of 10.2%, the market is projected to reach a valuation of US$ 831.3 Million by 2032. Ring Pessary is expected to be the highest revenue-generating category, projected to register a CAGR of 11.2% from 2022 to 2032.
|
Attributes |
Details |
|
Global Pessary Market Size (2022) |
US$ 316 Million |
|
Global Pessary Market Size (2032) |
US$ 831.3 Million |
|
Global Pessary Market CAGR (2022 to 2032) |
10.2% |
|
USA Pessary Market CAGR (2022 to 2032) |
11.1% |
|
Key Companies Covered |
|
Let us know your requirement to get
100% FREE customization
Revenue of Pessary Market from 2017 to 2021 Compared to Demand Outlook for 2022 to 2032
As per the Pessary Market research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Pessary Market increased at around 8.5% CAGR.
The aging population, together with pessaries' high success rate, has been driving the growth of the pessary market. Furthermore, lifestyle-related diseases are becoming more prevalent. The growing prevalence of diseases like pelvic organ prolapse and urinary incontinence will drive the pessary market. Furthermore, growing global awareness of the importance of pessaries during pelvic organ prolapse complications will serve as a growth driver.
For women with POP who want nonsurgical management, a future pregnancy, early-stage prolapse, or are too frail for surgery, pessaries are typically recommended as a first-line treatment option. Patients whose stress incontinence is aggravated by strenuous physical activity may benefit from pessaries. Pessaries provide an opportunity to simulate postsurgical conditions and help patients' expectations regarding symptom reduction in women who present with pelvic pain, back pain, and pressure thought to be caused by POP operations.
Several studies on the success rate of pessary fitting have been conducted, with results ranging from 41% to 74%. Success rates as high as 62 percent have been observed in patients with stage III and IV prolapse, suggesting that pessaries are an excellent option for all populations with severe POP. In the United States, approximately 200,000 POP operations are performed each year. Although not life-threatening, POP could have a major impact on women's standard of living.
What Factors are Propelling the Pessary Demand?
The Fourth International Consultation on Incontinence recommends pessaries, pelvic floor muscle training, and lifestyle counseling as conservative management options for women with Pelvic Organ Prolapse. Vaginal vault prolapse, or some other type of pelvic organ prolapse, affects approximately half of the women aged 50 to 80 years. Childbirth, age, fatness, gastrointestinal issues, or a hysterectomy can all cause uterine prolapse and increase the demand for pessaries.
Because they provide simple, affordable, and safe solutions, vaginal pessaries are a popular treatment option for organ prolapse and incontinence. These factors contribute to the higher patient satisfaction rate in comparison to an alternate solution. As a result, pessaries are now preferred as first-line treatment for POP or stress urinary incontinence.
Among the key factors expected to drive the market during the forecast period are frequent product introductions, a strong emphasis on Research and Development by market players and universities, geographical expansion by key players, and a number of government initiatives. The United Kingdom Clinical Guideline for Proper Procedure in the Use of Vaginal Pessaries for POP is a document prepared by medical professionals and supporters of prolapse pessaries. The goal of the Guideline is to provide multidisciplinary healthcare professionals with guidance and information on best practices in pessary use for prolapse.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystHow the emergence of Modern Pessaries pulled the growth trigger in Pessary Market?
Pessaries are now made of non-reactive silicone and come in a variety of designs and sizes to accommodate everyone. Silicon has low surface tension and remarkable chemical stability, allowing for biocompatibility and bio-durability in many long-term implant applications, making it suitable for medical applications.
Pessaries can be used as a stopgap measure for women who want to stop having children or are waiting for surgery. It can also be used as a long-term solution for women who do not qualify for surgery.
In June 2021, using artificial intelligence-driven machine learning and 3D design, Femtherapeutics Inc. developed a device to relieve urinary incontinence and discomfort in women suffering from pelvic organ prolapse. Unlike traditional pessaries, which can cause irritation and penetrate soft tissues, resulting in bleeding, the custom-made pessary is intended to support displaced vaginal tissues caused by the condition.
Region-wise Analysis
Which Region is projected to Offer the Largest Opportunity for Pessary Market?
Asia Pacific is the most lucrative region with double-digit projected growth. The fastest rate of expansion in the regional finance industry is predicted to result from younger, expanding populations and a growing focus on wellness.
As the elderly are more prone to incontinence and prolapsed organ disorders (POP), there is a sizable market in this region, with Japan, China, and India being the primary suppliers. Medical tourism is also a key driver behind the market's growth here.
In developing countries, the extent and effects of morbidity associated with pelvic organ prolapse are rarely acknowledged due to patient embarrassment. However, research funded by the United Nations Population Fund (UNFPA) in Nepal has begun to identify the suffering of women from this disorder. UNFPA is assisting in the identification of women with pelvic organ prolapse through reproductive health camps and the hiring of gynecologists to treat these women at district hospitals.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Country-wise Analysis
USA Pessary Market Analysis
The USA is expected to have the largest market of US$ 323.2 Million by the end of 2032 with North America being the dominant player and accounting for over 35% of total sales. With the elderly population in the United States increasing, there is renewed interest in pessaries as a less invasive alternative to surgical repair for pelvic organ prolapse (POP).
They are an excellent choice for women who have not finished having children, do not want surgery, or are ineligible for surgery. Patients suffering from POP and stress urinary incontinence may benefit from long-term pessary use. Although serious side effects are uncommon, many patients find it difficult to insert and remove most pessary types. The design of pessaries should continue to improve, making their use more appealing.
Women in the USA have an 11% lifetime risk of having prolapse or incontinence surgery by the age of 80, with a 30% chance of reoperation after four years. The number of women over the age of 65 in the USA is expected to more than double to reach more than 40 million by 2030, according to the USA Census Bureau.
As the United States population ages, there is renewed interest in the use of pessaries. According to a survey conducted by the American Urogynaecology Society, 77% of those polled used pessaries as their first-line POP therapy. The pessary is still a viable treatment option for prolapse and incontinence.
United Kingdom Pessary Market Analysis
The market in the United Kingdom is expected to gross US$ 42 Million by 2032. The market in the country is expected to witness a CAGR of 12.1% during the forecast period, registering an absolute dollar opportunity of US$ 28.2 Million.
Japan Pessary Market Analysis
In Japan, the market is expected to reach a valuation of US$ 30 Million by 2032. With an absolute dollar opportunity of US$ 20.7 Million during the forecast period, the market is expected to register a CAGR of 12.7%.
South Korea Pessary Market Analysis
The market in South Korea is expected to gross an absolute dollar opportunity of US$ 9.9 Million by 2032. Growing at a CAGR of 10.8% from 2022 to 2032, the market is likely to reach a valuation of US$ 15.5 Million.
Category-wise Insights
Which Pessary Segment is projected to Witness Most Opportunity?
The Ring Pessary segment is forecasted to grow at the highest CAGR of over 11% from 2022 to 2032. Because of their ease of insertion and removal, ring pessaries are typically the first-line pessary for clinicians. They can be used at any stage of POP, but the first and second stages are the most common. The catheter is unfolded once above the pubic symphysis after being inserted into the vagina. The pessary is gently pulled and folded in half to be removed. To help with insertion and removal, a string can be attached to the ring. Patients can easily learn how to do this on their own.
A new disposable, non-invasive vaginal ring pessary is used at home to treat a variety of pelvic floor disorders. The ConTIPI Medical ProVate, for example, is made of a flexible skeleton covered by a soft elastomer and is designed to expand in the vagina, separating the lateral vaginal walls and mechanically preventing cervical and vault descent as well as blocking further descent of the anterior and posterior walls within the rings hollow.
Which Product Type of Pessary is expected to Score the Highest Growth in the Coming Years?
The Hospitals segment is forecasted to grow at the highest CAGR of over 11.4% from 2022 to 2032. With 45% of the total revenue, the hospital segment dominated the vaginal pessary market. This could be attributed to the rising market demand for pessaries among post-operative and hospitalized indwellings. Among factors contributing to the segment's growth is the heightened interest in the notion of organ prolapse, urinary incontinence, and the inclusion of pessaries in private insurance policies. Surgeons are increasingly favoring minimally invasive procedures that will limit post-operation complications and increase recovery times.
Competitive Analysis
Among the leading players in the global Pessary market are Integra Lifesciences, Panpac Medical Corporation, Personal Medical Corporation, Dr. Arabin GmbH & Co., and Wallach Surgical Devices. To gain a competitive advantage in the industry, these market players are investing in product launches, partnerships, mergers and acquisitions, and expansions.
Some of the recent developments in the pessary market are mentioned below:
- In February 2022, CooperCompanies agreed to purchase Cook Medical's Reproductive Health division, which manufactures noninvasive fertility, obstetrics, and gynecology devices. Cooper will pay US$ 875 million in total, with US$ 675 million paid at closing and the remaining US$ 200 million paid in four US$ 50 million annual installments.
- In February 2022, Theramex, a global pharmaceutical company specializing in women's health expanded its initial collaboration with Endoceutics to commercialize Intrarosa in Australia. Intrarosa is the first and only DHEA treatment that has been approved for postmenopausal women suffering from moderate to severe vulvovaginal atrophy.
- In August 2021, Liv Labs developed a reusable female comfort pessary that does not require a doctor's prescription. Patients suffering from incontinence are currently fitted for pessaries, which must be worn for six months before being removed.
The Liv Labs pessary is soft, smooth, and squishy, making insertion and removal easier. It is made of medical-grade silicone. Women can use it whenever they want, whether it is all day or just for a quick trip to the gym.
Similarly, the team at Future Market Insights, which is available in the full report, has tracked recent developments related to companies in the Pessary market
Market Segments Covered in Pessary Market Analysis
By Type:
- Gellhorn
- Ring
- Donut
- Other Types
By End-Use:
- Hospitals
- Ambulatory Surgical Centres
- Clinics
By Region:
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
Frequently Asked Questions
How much is the current worth of the Pessary Market?
The global market is worth more than US$ 289.8 Million at present.
What is the sales forecast for Pessary Market?
The value of the Pessary Market is projected to increase at a CAGR of around 10.2% from 2022 to 2032.
What was the last 5 year’s market CAGR?
The value of the Pessary Market increased at a CAGR of around 8.5% from 2017 to 2021.
What is a key trend shaping the growth of the Pessary Market?
The increasing incidence of pelvic organ prolapse (POP), and urinary incontinence amongst the majority of women, stand as the key trend in the Pessary market.
At what percentage is sales of Pessary Market going to register growth in USA?
The pessary Market in the USA is projected to expand at a CAGR of around 11.1% from 2022 to 2032.
Table of Content
1. Executive Summary | Pessary Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Investment Feasibility Matrix 3.4. PESTLE and Porter’s Analysis 4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032 4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021 4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Type, 2017 to 2021 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2022 to 2032 5.3.1. Gellhorn 5.3.2. Ring 5.3.3. Donut 5.3.4. Other Types 5.4. Y-o-Y Growth Trend Analysis By Type, 2017 to 2021 5.5. Absolute $ Opportunity Analysis By Type, 2022 to 2032 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2017 to 2021 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2022 to 2032 6.3.1. Hospitals 6.3.2. Ambulatory Surgical Centres 6.3.3. Clinics 6.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2021 6.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021 7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. East Asia 7.3.5. South Asia 7.3.6. Oceania 7.3.7. Middle East and Africa(MEA) 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 8.2.1. By Country 8.2.1.1. USA 8.2.1.2. Canada 8.2.2. By Type 8.2.3. By End User 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Type 8.3.3. By End User 8.4. Key Takeaways 9. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Argentina 9.2.1.4. Rest of Latin America 9.2.2. By Type 9.2.3. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Type 9.3.3. By End User 9.4. Key Takeaways 10. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. Italy 10.2.1.3. France 10.2.1.4. United Kingdom 10.2.1.5. Spain 10.2.1.6. Russia 10.2.1.7. BENELUX 10.2.1.8. Rest of Europe 10.2.2. By Type 10.2.3. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Type 10.3.3. By End User 10.4. Key Takeaways 11. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 11.2.1. By Country 11.2.1.1. China 11.2.1.2. Japan 11.2.1.3. South Korea 11.2.2. By Type 11.2.3. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Type 11.3.3. By End User 11.4. Key Takeaways 12. South Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Thailand 12.2.1.3. Malaysia 12.2.1.4. Indonesia 12.2.1.5. Rest of South Asia 12.2.2. By Type 12.2.3. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Type 12.3.3. By End User 12.4. Key Takeaways 13. Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 13.2.1. By Country 13.2.1.1. Australia 13.2.1.2. New Zealand 13.2.2. By Type 13.2.3. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Type 13.3.3. By End User 13.4. Key Takeaways 14. MEA Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. Rest of Middle East and Africa(MEA) 14.2.2. By Type 14.2.3. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Type 14.3.3. By End User 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. USA 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2021 15.1.2.1. By Type 15.1.2.2. By End User 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2021 15.2.2.1. By Type 15.2.2.2. By End User 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2021 15.3.2.1. By Type 15.3.2.2. By End User 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2021 15.4.2.1. By Type 15.4.2.2. By End User 15.5. Argentina 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2021 15.5.2.1. By Type 15.5.2.2. By End User 15.6. Germany 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2021 15.6.2.1. By Type 15.6.2.2. By End User 15.7. Italy 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2021 15.7.2.1. By Type 15.7.2.2. By End User 15.8. France 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2021 15.8.2.1. By Type 15.8.2.2. By End User 15.9. United Kingdom 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2021 15.9.2.1. By Type 15.9.2.2. By End User 15.10. Spain 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2021 15.10.2.1. By Type 15.10.2.2. By End User 15.11. Russia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2021 15.11.2.1. By Type 15.11.2.2. By End User 15.12. BENELUX 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2021 15.12.2.1. By Type 15.12.2.2. By End User 15.13. China 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2021 15.13.2.1. By Type 15.13.2.2. By End User 15.14. Japan 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2021 15.14.2.1. By Type 15.14.2.2. By End User 15.15. South Korea 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2021 15.15.2.1. By Type 15.15.2.2. By End User 15.16. India 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2021 15.16.2.1. By Type 15.16.2.2. By End User 15.17. Thailand 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2021 15.17.2.1. By Type 15.17.2.2. By End User 15.18. Malaysia 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2021 15.18.2.1. By Type 15.18.2.2. By End User 15.19. Indonesia 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2021 15.19.2.1. By Type 15.19.2.2. By End User 15.20. Australia 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2021 15.20.2.1. By Type 15.20.2.2. By End User 15.21. New Zealand 15.21.1. Pricing Analysis 15.21.2. Market Share Analysis, 2021 15.21.2.1. By Type 15.21.2.2. By End User 15.22. GCC Countries 15.22.1. Pricing Analysis 15.22.2. Market Share Analysis, 2021 15.22.2.1. By Type 15.22.2.2. By End User 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Type 16.3.3. By End User 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. MedGyn Products, Inc. 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments (Product/Age /Sales Channel/Region) 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.1.5.2. Product Strategy 17.1.1.5.3. Channel Strategy 17.1.2. Cooper Surgical Inc. 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments (Product/Age /Sales Channel/Region) 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.2.5.2. Product Strategy 17.1.2.5.3. Channel Strategy 17.1.3. Personal Medical Corp. 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments (Product/Age /Sales Channel/Region) 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.3.5.2. Product Strategy 17.1.3.5.3. Channel Strategy 17.1.4. Panpac Medical Corp 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments (Product/Age /Sales Channel/Region) 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.4.5.2. Product Strategy 17.1.4.5.3. Channel Strategy 17.1.5. Smiths Medical 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments (Product/Age /Sales Channel/Region) 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.5.5.2. Product Strategy 17.1.5.5.3. Channel Strategy 17.1.6. Thomas Medical 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments (Product/Age /Sales Channel/Region) 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.6.5.2. Product Strategy 17.1.6.5.3. Channel Strategy 17.1.7. Artisan Medical 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments (Product/Age /Sales Channel/Region) 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.7.5.2. Product Strategy 17.1.7.5.3. Channel Strategy 17.1.8. Bioteque America, Inc. 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments (Product/Age /Sales Channel/Region) 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.8.5.2. Product Strategy 17.1.8.5.3. Channel Strategy 17.1.9. Integra LifeSciences Corporation 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments (Product/Age /Sales Channel/Region) 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.9.5.2. Product Strategy 17.1.9.5.3. Channel Strategy 17.1.10. Dr. Arabin GmbH & Co. 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments (Product/Age /Sales Channel/Region) 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.10.5.2. Product Strategy 17.1.10.5.3. Channel Strategy 17.1.11. Medgyn Products, Inc. 17.1.11.1. Overview 17.1.11.2. Product Portfolio 17.1.11.3. Profitability by Market Segments (Product/Age /Sales Channel/Region) 17.1.11.4. Sales Footprint 17.1.11.5. Strategy Overview 17.1.11.5.1. Marketing Strategy 17.1.11.5.2. Product Strategy 17.1.11.5.3. Channel Strategy 17.1.12. Wallach Surgical Devices 17.1.12.1. Overview 17.1.12.2. Product Portfolio 17.1.12.3. Profitability by Market Segments (Product/Age /Sales Channel/Region) 17.1.12.4. Sales Footprint 17.1.12.5. Strategy Overview 17.1.12.5.1. Marketing Strategy 17.1.12.5.2. Product Strategy 17.1.12.5.3. Channel Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2017 to 2032 Table 2: Global Market Value (US$ Million) Forecast by Type, 2017 to 2032 Table 3: Global Market Value (US$ Million) Forecast by End User, 2017 to 2032 Table 4: North America Market Value (US$ Million) Forecast by Country, 2017 to 2032 Table 5: North America Market Value (US$ Million) Forecast by Type, 2017 to 2032 Table 6: North America Market Value (US$ Million) Forecast by End User, 2017 to 2032 Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2017 to 2032 Table 8: Latin America Market Value (US$ Million) Forecast by Type, 2017 to 2032 Table 9: Latin America Market Value (US$ Million) Forecast by End User, 2017 to 2032 Table 10: Europe Market Value (US$ Million) Forecast by Country, 2017 to 2032 Table 11: Europe Market Value (US$ Million) Forecast by Type, 2017 to 2032 Table 12: Europe Market Value (US$ Million) Forecast by End User, 2017 to 2032 Table 13: East Asia Market Value (US$ Million) Forecast by Country, 2017 to 2032 Table 14: East Asia Market Value (US$ Million) Forecast by Type, 2017 to 2032 Table 15: East Asia Market Value (US$ Million) Forecast by End User, 2017 to 2032 Table 16: South Asia Market Value (US$ Million) Forecast by Country, 2017 to 2032 Table 17: South Asia Market Value (US$ Million) Forecast by Type, 2017 to 2032 Table 18: South Asia Market Value (US$ Million) Forecast by End User, 2017 to 2032 Table 19: Oceania Market Value (US$ Million) Forecast by Country, 2017 to 2032 Table 20: Oceania Market Value (US$ Million) Forecast by Type, 2017 to 2032 Table 21: Oceania Market Value (US$ Million) Forecast by End User, 2017 to 2032 Table 22: MEA Market Value (US$ Million) Forecast by Country, 2017 to 2032 Table 23: MEA Market Value (US$ Million) Forecast by Type, 2017 to 2032 Table 24: MEA Market Value (US$ Million) Forecast by End User, 2017 to 2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Market Value (US$ Million) by Type, 2022 to 2032 Figure 2: Global Market Value (US$ Million) by End User, 2022 to 2032 Figure 3: Global Market Value (US$ Million) by Region, 2022 to 2032 Figure 4: Global Market Value (US$ Million) Analysis by Region, 2017 to 2032 Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2022 to 2032 Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2022 to 2032 Figure 7: Global Market Value (US$ Million) Analysis by Type, 2017 to 2032 Figure 8: Global Market Value Share (%) and BPS Analysis by Type, 2022 to 2032 Figure 9: Global Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032 Figure 10: Global Market Value (US$ Million) Analysis by End User, 2017 to 2032 Figure 11: Global Market Value Share (%) and BPS Analysis by End User, 2022 to 2032 Figure 12: Global Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032 Figure 13: Global Market Attractiveness by Type, 2022 to 2032 Figure 14: Global Market Attractiveness by End User, 2022 to 2032 Figure 15: Global Market Attractiveness by Region, 2022 to 2032 Figure 16: North America Market Value (US$ Million) by Type, 2022 to 2032 Figure 17: North America Market Value (US$ Million) by End User, 2022 to 2032 Figure 18: North America Market Value (US$ Million) by Country, 2022 to 2032 Figure 19: North America Market Value (US$ Million) Analysis by Country, 2017 to 2032 Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032 Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032 Figure 22: North America Market Value (US$ Million) Analysis by Type, 2017 to 2032 Figure 23: North America Market Value Share (%) and BPS Analysis by Type, 2022 to 2032 Figure 24: North America Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032 Figure 25: North America Market Value (US$ Million) Analysis by End User, 2017 to 2032 Figure 26: North America Market Value Share (%) and BPS Analysis by End User, 2022 to 2032 Figure 27: North America Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032 Figure 28: North America Market Attractiveness by Type, 2022 to 2032 Figure 29: North America Market Attractiveness by End User, 2022 to 2032 Figure 30: North America Market Attractiveness by Country, 2022 to 2032 Figure 31: Latin America Market Value (US$ Million) by Type, 2022 to 2032 Figure 32: Latin America Market Value (US$ Million) by End User, 2022 to 2032 Figure 33: Latin America Market Value (US$ Million) by Country, 2022 to 2032 Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2017 to 2032 Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032 Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032 Figure 37: Latin America Market Value (US$ Million) Analysis by Type, 2017 to 2032 Figure 38: Latin America Market Value Share (%) and BPS Analysis by Type, 2022 to 2032 Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032 Figure 40: Latin America Market Value (US$ Million) Analysis by End User, 2017 to 2032 Figure 41: Latin America Market Value Share (%) and BPS Analysis by End User, 2022 to 2032 Figure 42: Latin America Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032 Figure 43: Latin America Market Attractiveness by Type, 2022 to 2032 Figure 44: Latin America Market Attractiveness by End User, 2022 to 2032 Figure 45: Latin America Market Attractiveness by Country, 2022 to 2032 Figure 46: Europe Market Value (US$ Million) by Type, 2022 to 2032 Figure 47: Europe Market Value (US$ Million) by End User, 2022 to 2032 Figure 48: Europe Market Value (US$ Million) by Country, 2022 to 2032 Figure 49: Europe Market Value (US$ Million) Analysis by Country, 2017 to 2032 Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2022 to 2032 Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032 Figure 52: Europe Market Value (US$ Million) Analysis by Type, 2017 to 2032 Figure 53: Europe Market Value Share (%) and BPS Analysis by Type, 2022 to 2032 Figure 54: Europe Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032 Figure 55: Europe Market Value (US$ Million) Analysis by End User, 2017 to 2032 Figure 56: Europe Market Value Share (%) and BPS Analysis by End User, 2022 to 2032 Figure 57: Europe Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032 Figure 58: Europe Market Attractiveness by Type, 2022 to 2032 Figure 59: Europe Market Attractiveness by End User, 2022 to 2032 Figure 60: Europe Market Attractiveness by Country, 2022 to 2032 Figure 61: East Asia Market Value (US$ Million) by Type, 2022 to 2032 Figure 62: East Asia Market Value (US$ Million) by End User, 2022 to 2032 Figure 63: East Asia Market Value (US$ Million) by Country, 2022 to 2032 Figure 64: East Asia Market Value (US$ Million) Analysis by Country, 2017 to 2032 Figure 65: East Asia Market Value Share (%) and BPS Analysis by Country, 2022 to 2032 Figure 66: East Asia Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032 Figure 67: East Asia Market Value (US$ Million) Analysis by Type, 2017 to 2032 Figure 68: East Asia Market Value Share (%) and BPS Analysis by Type, 2022 to 2032 Figure 69: East Asia Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032 Figure 70: East Asia Market Value (US$ Million) Analysis by End User, 2017 to 2032 Figure 71: East Asia Market Value Share (%) and BPS Analysis by End User, 2022 to 2032 Figure 72: East Asia Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032 Figure 73: East Asia Market Attractiveness by Type, 2022 to 2032 Figure 74: East Asia Market Attractiveness by End User, 2022 to 2032 Figure 75: East Asia Market Attractiveness by Country, 2022 to 2032 Figure 76: South Asia Market Value (US$ Million) by Type, 2022 to 2032 Figure 77: South Asia Market Value (US$ Million) by End User, 2022 to 2032 Figure 78: South Asia Market Value (US$ Million) by Country, 2022 to 2032 Figure 79: South Asia Market Value (US$ Million) Analysis by Country, 2017 to 2032 Figure 80: South Asia Market Value Share (%) and BPS Analysis by Country, 2022 to 2032 Figure 81: South Asia Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032 Figure 82: South Asia Market Value (US$ Million) Analysis by Type, 2017 to 2032 Figure 83: South Asia Market Value Share (%) and BPS Analysis by Type, 2022 to 2032 Figure 84: South Asia Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032 Figure 85: South Asia Market Value (US$ Million) Analysis by End User, 2017 to 2032 Figure 86: South Asia Market Value Share (%) and BPS Analysis by End User, 2022 to 2032 Figure 87: South Asia Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032 Figure 88: South Asia Market Attractiveness by Type, 2022 to 2032 Figure 89: South Asia Market Attractiveness by End User, 2022 to 2032 Figure 90: South Asia Market Attractiveness by Country, 2022 to 2032 Figure 91: Oceania Market Value (US$ Million) by Type, 2022 to 2032 Figure 92: Oceania Market Value (US$ Million) by End User, 2022 to 2032 Figure 93: Oceania Market Value (US$ Million) by Country, 2022 to 2032 Figure 94: Oceania Market Value (US$ Million) Analysis by Country, 2017 to 2032 Figure 95: Oceania Market Value Share (%) and BPS Analysis by Country, 2022 to 2032 Figure 96: Oceania Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032 Figure 97: Oceania Market Value (US$ Million) Analysis by Type, 2017 to 2032 Figure 98: Oceania Market Value Share (%) and BPS Analysis by Type, 2022 to 2032 Figure 99: Oceania Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032 Figure 100: Oceania Market Value (US$ Million) Analysis by End User, 2017 to 2032 Figure 101: Oceania Market Value Share (%) and BPS Analysis by End User, 2022 to 2032 Figure 102: Oceania Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032 Figure 103: Oceania Market Attractiveness by Type, 2022 to 2032 Figure 104: Oceania Market Attractiveness by End User, 2022 to 2032 Figure 105: Oceania Market Attractiveness by Country, 2022 to 2032 Figure 106: MEA Market Value (US$ Million) by Type, 2022 to 2032 Figure 107: MEA Market Value (US$ Million) by End User, 2022 to 2032 Figure 108: MEA Market Value (US$ Million) by Country, 2022 to 2032 Figure 109: MEA Market Value (US$ Million) Analysis by Country, 2017 to 2032 Figure 110: MEA Market Value Share (%) and BPS Analysis by Country, 2022 to 2032 Figure 111: MEA Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032 Figure 112: MEA Market Value (US$ Million) Analysis by Type, 2017 to 2032 Figure 113: MEA Market Value Share (%) and BPS Analysis by Type, 2022 to 2032 Figure 114: MEA Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032 Figure 115: MEA Market Value (US$ Million) Analysis by End User, 2017 to 2032 Figure 116: MEA Market Value Share (%) and BPS Analysis by End User, 2022 to 2032 Figure 117: MEA Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032 Figure 118: MEA Market Attractiveness by Type, 2022 to 2032 Figure 119: MEA Market Attractiveness by End User, 2022 to 2032 Figure 120: MEA Market Attractiveness by Country, 2022 to 2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
